Respiratory Disease Management Platform: Empowering Asthma and COPD Patients through connected self-care

The Respiratory Disease Management Platform (ADH RDMP) is a CE marked self-management platform designed to support people with
asthma and COPD, developed by Aptar Digital Health.

COPD and asthma patients seeking better control and personalized support can use the Respi.me mobile application in combination with:

• A connected inhaler sensor (The HeroTracker Sense) to monitor technique and adherence
• A Bluetooth spirometer to record lung function (FEV1, FVC, PEF)
• Features like symptom and trigger tracking, physical activity monitoring, and tailored education

Healthcare professionals can access real-time data via the Respi.me Connect portal for remote monitoring and support. The platform can also be used by Hospitals and healthcare systems looking to improve asthma outcomes and reduce exacerbations, as well as researchers and digital health innovators interested in evaluating or integrating asthma management tools or Pharmaceutical companies interested in real-world data collection and adherence monitoring for clinical trials.

The platform is CE-marked and available through license agreements, with pricing models likely based on deployment scale and service area. The HeroTracker® Sense inhaler sensor is both CE-marked and FDA-cleared, ensuring regulatory compliance for use in clinical and commercial settings.